Open Access Open Access  Restricted Access Subscription Access

Causes, Symptoms, Diagnosis And Treatment of Hepatitis B: A Comprehensive Report

Ambica Prasad M., Sravani Pragna K., Ramanjaneyulu D. V., Muralinath E., Pooja Devi, Prasanta Chbukdhara, Sanjib Borah, Kalyan C., Archana Jain, Guruprasad M.

Abstract


In most cases, Hepatitis B causes both inflammation and infection.  Chronic cases result in irreversible liver damage as the virus attacks the liver over time without being noticed.  The authors  provide an information regarding symptoms,early symptoms, diagnosis  and  treatment.


Full Text:

PDF

References


Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, Szmuness W, Chen KP. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis. 1982 Aug;146(2):198-204. [PubMed]

Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, Mares A, Miller JK, Moyer LA. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA. 1990 Mar 02;263(9):1218-22. [PubMed]

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018 Apr;67(4):1560-1599. [PMC free article] [PubMed]

Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology. 2012 Aug;56(2):422-33. [PubMed]

Higgins DC, Kuncio DE, Johnson CC, Viner KM. Influence of birth origin and risk factor profile on hepatitis B mortality: Philadelphia, PA 2003-2013. Ann Epidemiol. 2018 Mar;28(3):169-174. [PubMed]

Nebbia G, Peppa D, Maini MK. Hepatitis B infection: current concepts and future challenges. QJM. 2012 Feb;105(2):109-13. [PMC free article] [PubMed]

Kuo A, Gish R. Chronic hepatitis B infection. Clin Liver Dis. 2012 May;16(2):347-69. [PubMed]

Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris). 2010 Aug;58(4):258-66. [PMC free article] [PubMed]

Mani H, Kleiner DE. Liver biopsy findings in chronic hepatitis B. Hepatology. 2009 May;49(5 Suppl):S61-71. [PubMed]

Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014 Dec 06;384(9959):2053-63. [PubMed]

Kim BK, Revill PA, Ahn SH. HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B. Antivir Ther. 2011;16(8):1169-86. [PubMed]

Luo A, Jiang X, Ren H. Entecavir-based combination therapies for chronic hepatitis B: A meta-analysis. Medicine (Baltimore). 2018 Dec;97(51):e13596. [PMC free article] [PubMed]

Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, Hu JJ, Lin HH, Zhao LL, Mu SC, Lai MW, Lee CL, Lin HM, Tsai MS, Hsu JJ, Chen DS, Chan KA, Chang MH., Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study). Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV PreMIT Study. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology. 2015 Aug;62(2):375-86. [PubMed]

Lok AS, Lai CL, Leung N, Yao GB, Cui ZY, Schiff ER, Dienstag JL, Heathcote EJ, Little NR, Griffiths DA, Gardner SD, Castiglia M. Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology. 2003 Dec;125(6):1714-22. [PubMed]

Chen CH, Lin CL, Hu TH, Hung CH, Tseng PL, Wang JH, Chang JY, Lu SN, Chien RN, Lee CM. Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation. J Hepatol. 2014 Jun;60(6):1127-34. [PubMed]


Refbacks

  • There are currently no refbacks.